Article History
Accepted: 5 August 2021
First Online: 15 September 2021
Declarations
:
: Not applicable
: LPB Elbers has no financial disclosures to declare. HG Raterman has received consultancy fees from Amgen and UCB. WF Lems has received consultancy fees from Merck Sharp and Dohme, Amgen Inc, Eli Lilly and Company and UCB Pharma.
: Not applicable
: Not applicable
: LPBE: formal analysis, writing-original draft, writing—review and editing, visualization HGR: writing-original draft, writing—review and editing, visualization, supervision WFL: conceptualization, writing—review and editing, supervision. All authors approved the final version of the manuscript.